Basel Medical Group Ltd (BMGL)

Basel Medical Group Balance Sheet

Financials in millions SGD. Fiscal year is July - June.

Year Ending	TTM	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	0.94	1.22	1.56
Short-Term Investments	12.12	11.88	11.75
Cash & Cash Equivalents	13.06	13.1	13.32
Cash Growth	-	-1.67%	-
Receivables	-	1.58	2.28
Inventory	-	0.09	0.07
Total Current Assets	-	14.77	15.67
Property, Plant & Equipment	-	0.06	0.08
Goodwill and Intangibles	-	0.52	1.1
Other Long-Term Assets	-	0.03	0
Total Long-Term Assets	-	0.61	1.18
Total Assets	-	15.38	16.85
Accounts Payable	-	2.19	2.41
Current Debt	-	3.79	4.38
Other Current Liabilities	-	0.49	0.41
Total Current Liabilities	-	6.47	7.19
Long-Term Debt	-	3.42	5.95
Total Long-Term Liabilities	-	3.42	5.95
Total Liabilities	-	9.89	13.14
Total Debt	6.88	7.21	10.32
Debt Growth	-	-30.14%	-
Retained Earnings	-	5.49	3.71
Shareholders' Equity	6.82	5.49	3.71
Net Cash / Debt	6.18	5.88	2.99
Net Cash / Debt Growth	-	96.54%	-
Working Capital	-	8.31	8.47

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).